Korian : Q2 sales in line / COVID impact of € 58m on H1 EBITDA – no guidance but sharp improvement since June – positive opinion maintained
>Q2 hit by the coronavirus (notably in Italy) - Q2 sales totalled € 934.9m (+4.4% and -1.6% l-fl-l), i.e. € 1,877m, for H1. Excluding Italy, organic growth stands at +1.4%. EBITDAR at the end of June amounted to € 443m (23.6% of revenue) and € 463m, restated for the exceptional charges linked to COVID-19. EBITDA stood at € 407m or € 227m excluding IFRS 16 vs € 258m in H1 2019, impacted by COVID. Net profit combines several parameters (COVID costs, one off costs linked...Korian is an actor on the temporary and permanent dependency care market in France, Germany and Italy. Co. offers and develops services related to dependency through its retirement homes (116 as of Dec 31 2009), follow-up care and rehabilitation facilities (35 as of Dec 31 2009) and psychiatric clinics (11 as of Dec 31 2009). Co.'s operations can be divided into four geographical segments: Medical and Social activity in France (retirement homes); Sanitary activity in France (follow-up care, rehabilitation, psychiatry and home medical care); Italy; and Germany.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.